{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiama67geehaehttgsv4f3xgliv4kritqljumpxwrbyi7ahp7ftyta",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnkl3xynrae2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifnvz5va3o5uoljjo5utiibkcawtl2dwmhdjxo42g65ww4poxqbd4"
    },
    "mimeType": "image/jpeg",
    "size": 885642
  },
  "path": "/news/2026-06-flu-drugs-cognitive-decline.html",
  "publishedAt": "2026-06-05T11:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials. The findings point to a potential new therapy for cognitive problems in people with HIV, with broader implications for other aging-related diseases, such as dementia. The study is published in Med.",
  "title": "Flu drugs show promise against cognitive decline"
}